Are PIK3CA mutation and amplification associated with clinicopathological characteristics of gastric cancer?

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 11, 2015, Pages 4493-4496

  Lee, Hyunsu ^a   Hwang, Il Seon ^a   Choi, In Jang ^a   Kang, Yu Na ^a   Park, Keon Uk ^a   Lee, Jae Ho ^a  

^a Keimyung University   (South Korea)

Author keywords

Copy number; Gastric cancer; Mitochondrial DNA; Prognosis

Indexed keywords

MITOCHONDRIAL DNA; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; CANCER STAGING; COPY NUMBER VARIATION; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MITOCHONDRION; MORTALITY; MUTATION; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY; STOMACH; STOMACH TUMOR; SURVIVAL RATE; TUMOR INVASION;

ADENOCARCINOMA; BIOMARKERS, TUMOR; DNA COPY NUMBER VARIATIONS; DNA, MITOCHONDRIAL; FEMALE; FOLLOW-UP STUDIES; GENE AMPLIFICATION; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOCHONDRIA; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84936980896     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.11.4493     Document Type: Article

References (26)

1. Bertelsen BI, Steine SJ, Sandvei R, Molven A, Laerum OD (2006). Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation. Int J Cancer, 118, 1877-83.
2. Byun DS, Cho K, Ryu BK, et al (2003). Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma. Int J Cancer, 104, 318-27.
3. Campbell IG, Russell SE, Choong DY, et al (2004). Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res, 64, 7678-81.
4. Cancer Genome Atlas Research N (2014). Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513, 202-9.
5. Correa P (1992). Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res, 52, 6735-40.
6. Correa P, Shiao YH (1994). Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res, 54, 1941-3.
7. Garcia-Rostan G, Costa AM, Pereira-Castro I, et al (2005). Mutation of the PIK3CA gene in anaplastic thyroid cancer. Cancer Res, 65, 10199-207.
8. Gray JW, Collins C (2000). Genome changes and gene expression in human solid tumors. Carcinogenesis, 21, 443-52.
9. Kandula M, Chennaboina KK, Ammi Raju Y, Raju S (2013). Phosphatidylinositol 3-kinase (PI3KCA) oncogene mutation analysis and gene expression profiling in primary breast cancer patients. Asian Pac J Cancer Prev, 14, 5067-72.
10. Kato S, Iida S, Higuchi T, et al (2007). PIK3CA mutation is predictive of poor survival in patients with colorectal cancer. Int J Cancer, 121, 1771-8.
11. Lee JW, Soung YH, Kim SY, et al (2005). PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene, 24, 1477-80.
12. Leung WK, Kim JJ, Kim JG, Graham DY, Sepulveda AR (2000). Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol, 156, 537-43.
13. Lin Y, Jiang X, Shen Y, et al (2009). Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors. Endocr Relat Cancer, 16, 301-10.
14. Ma YY, Wei SJ, Lin YC, et al (2000). PIK3CA as an oncogene in cervical cancer. Oncogene, 19, 2739-44.
15. Michl P, Downward J (2005). Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers. Z Gastroenterol, 43, 1133-9.
16. Ottini L, Falchetti M, Lupi R, et al (2006). Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol, 17, 97-102.
17. Qu JL, Qu XJ, Zhao MF, et al (2009). Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis, 41, 875-80.
18. Samuels Y, Wang Z, Bardelli A, et al (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science, 304, 554.
19. Shayesteh L, Lu Y, Kuo WL, et al (1999). PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet, 21, 99-102.
20. Shi J, Yao D, Liu W, et al (2012). Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer. BMC Cancer, 12, 50.
21. Velho S, Oliveira C, Ferreira A, et al (2005). The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer, 41, 1649-54.
22. Wu G, Xing M, Mambo E, et al (2005). Somatic mutation and gain of copy number of PIK3CA in human breast cancer. Breast Cancer Res, 7, 609-16.
23. Yamamoto H, Shigematsu H, Nomura M, et al (2008). PIK3CA mutations and copy number gains in human lung cancers. Cancer Res, 68, 6913-21.
24. Yamamoto S, Tsuda H, Takano M, et al (2011). PIK3CA mutation is an early event in the development of endometriosisassociated ovarian clear cell adenocarcinoma. J Pathol, 225, 189-94.
25. Yu HG, Ai YW, Yu LL, et al (2008). Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer, 122, 433-43.
26. Zhang D, Wang Z, Luo Y, et al (2011). Analysis of DNA copy number aberrations by multiple ligation-dependent probe amplification on 50 intestinal type gastric cancers. J Surg Oncol, 103, 124-32.